Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...

Explore technical features and comparative strengths of MaxQuant, Proteome Discoverer, FragPipe, and DIA-NN workflows.

Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.

Ion mobility adds a powerful new dimension to biopharma separations as complex therapeutics outgrow traditional LC–MS.

Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global mass spectrometry market was valued at 6.42 billion in 2024 and is expected to reach US$ 12.06 billion by 2033, growing at a CAGR of 7.85% from ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

Tandem mass spectrometry is a powerful tool in proteomics. By ionizing peptides and then fragmenting those ions into smaller product ions, researchers can determine the biomolecules’ amino acid ...

STARKVILLE, Miss.—Amanda Patrick, an assistant professor in Mississippi State University’s Department of Chemistry, is one of only 19 early career scientists globally to be named an “Emerging ...

Drug discovery requires two separate steps: checking whether a drug can bind to a harmful molecule or its receptor, and ...

Membrane proteins are vital for cellular signaling, transport, and communication, making them attractive drug targets despite their challenging properties. Advances in mass spectrometry have enabled ...